Wang Ailing, Wang Xiaoyan, Dou Lixia, Wang Fang, Wang Qian, Qiao Yaping, Su Min, Jin Xi
National Center for Women and Children's Health, Chinese Center for Disease Control and Prevention, Beijing 100101, China.
National Center for Women and Children's Health, Chinese Center for Disease Control and Prevention, Beijing 100101, China; Email:
Zhonghua Liu Xing Bing Xue Za Zhi. 2015 Apr;36(4):349-53.
To measure the incidence rates of preterm delivery in HIV-infected pregnant women and to explore related potential risk factors.
Data from 'Information System of Prevention of Mother-to-child Transmission of HIV Management in China, 2013' was used in the study. Information regarding demographic characteristics, pregnancy, HIV relevant situations and pregnancy outcomes related to these HIV-infected pregnant women, were extracted and analyzed. Incidence of preterm delivery was calculated with related potential risk factors explored.
3 913 HIV-infected pregnant women were involved in this study, including 336 of them having undergone preterm deliveries (8.6%). Results from univariate and multivariate analyses showed that preterm delivery was associated with factors as: maternal age, ethnicity, education, being migrant, pregnancy hypertension, multiple pregnancy and times of antenatal care visits (P < 0.05) of the pregnant women. Compared with those who contracted the HIV infection through drug injection, the ones who were infected through other routes suffered fewer preterm deliveries (adjusted OR = 0.562, 95% CI: 0.360-0.879). Pregnant women who received antiretroviral therapy either between 14 to 27 gestational weeks or during the period of less than 14, were more likely to experience preterm delivery, comparison to those who did not receive the therapy during pregnancy. The adjusted ORs were 1.712 (95% CI: 1.196-2.451) and 1.862 (95% CI: 1.261-2.749), respectively.
Preterm delivery was a common adverse outcome during pregnancy among HIV-infected women in China. Other than traditionally known risk factors, routes of transmission and the use of antiretroviral therapy might also be associated with the increased risks for preterm delivery.
测量感染人类免疫缺陷病毒(HIV)的孕妇的早产发生率,并探讨相关潜在危险因素。
本研究使用了“2013年中国预防艾滋病母婴传播管理信息系统”的数据。提取并分析了这些感染HIV的孕妇的人口统计学特征、妊娠情况、HIV相关情况及妊娠结局等信息。计算早产发生率并探讨相关潜在危险因素。
本研究纳入3913例感染HIV的孕妇,其中336例发生早产(8.6%)。单因素和多因素分析结果显示,早产与孕妇的年龄、种族、教育程度、是否为流动人口、妊娠高血压、多胎妊娠及产前检查次数等因素有关(P<0.05)。与通过注射毒品感染HIV的孕妇相比,通过其他途径感染的孕妇早产发生率较低(校正比值比=0.562,95%可信区间:0.360-0.879)。与孕期未接受抗逆转录病毒治疗的孕妇相比,在妊娠14至27周期间或妊娠14周以内接受抗逆转录病毒治疗的孕妇更易发生早产。校正比值比分别为1.712(95%可信区间:1.196-2.451)和1.862(95%可信区间:1.261-2.749)。
在中国,早产是感染HIV的孕妇妊娠期间常见的不良结局。除了传统已知的危险因素外,传播途径及抗逆转录病毒治疗的使用也可能与早产风险增加有关。